Navigation Links
New therapy provides hope for millions of people suffering from bowel incontinence
Date:7/18/2011

CHICAGO- A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function. It is one of the only effective long-term treatments for bowel incontinence available to patients and Northwestern Memorial Hospital is one of the first medical centers in the country to offer the procedure.

"Bowel control problems can have a significant, detrimental effect on a person's emotional well-being," said Anne-Marie Boller, MD, a colon rectal surgeon at Northwestern Memorial. "Patients often struggle with everyday activities and withdraw from social interactions due to embarrassment or fear, causing them to suffer in silence. This treatment is a tremendous advancement that has the potential to improve patients' bowel control and their quality of life."

InterStim Therapy has been shown to reduce or eliminate bowel incontinence in 80 percent of patients according to recent studies. The treatment involves three steps: test stimulation, surgical implant and post-implant follow up. During the first phase, a thin wire is placed to stimulate the sacral nerve. This allows doctors to determine if the patient is likely to benefit from the therapy before moving forward with the full procedure. If the trial phase is successful, a long-term neurostimulator device, similar to a pacemaker, is then implanted in the buttock. The device has adjustable settings that can be tailored to the patient needs, and over time can be controlled by the patient using a programmer which works like a remote control. The final phase is follow-up monitoring.

"Until now, few treatments have been successful in treating bowel incontinence," said Amy Halverson, MD, a colon rectal surgeon at Northwestern Memorial. "This is an exciting new option that will give many patients their freedom back by eliminating symptoms. We are excited to be able to offer this to patients."

InterStim Therapy, previously available for treating symptoms of overactive bladder was recently approved by the U.S. Food and Drug Administration (FDA) for fecal incontinence. "We have been waiting for FDA approval for almost ten years for bowel control use, many of our patients had to seek treatment in other countries where the therapy was already approved," added Boller also an assistant professor of surgery in the division of gastrointestinal and oncologic surgery at Northwestern University Feinberg School of Medicine. To date, more than 85,000 people have received InterStim Therapy worldwide.

Physicians tout the ability to determine the probable success of the therapy before committing to the full procedure as one of the many benefits.

Fecal incontinence is most common in adults, predominately women, and is not a normal part of aging. The disorder can be caused by a variety of factors, including damage to the nerves or muscles in the anal canal and sphincter from trauma such as childbirth, or other pelvic health disorders.

"People should not be embarrassed and should not dismiss symptoms because they think it is a normal sign of getting older," said Halverson who is also an associate professor of surgery in the division of gastrointestinal and oncologic surgery at Feinberg School of Medicine. "Bowel incontinence may be unpleasant, but thanks to new therapies, you can stop symptoms and take back control of your life," said Boller.

Halverson and Boller are among the only physicians in the Chicago area offering this procedure. For more information, please visit the Northwestern Integrated Pelvic Health Program or call 312-926-0779.


'/>"/>

Contact: Angela Salerno
asalerno@nmh.org
312-926-8327
Northwestern Memorial Hospital
Source:Eurekalert

Related medicine news :

1. Novel combined therapy extends life, diminishes pain in brain cancer patients
2. Virtual Reality May Help in Parkinsons Therapy
3. Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors
4. Special Talk Therapy Seems to Help Dying Patients
5. New Combo Therapy May Prevent TB, Save Lives in People With HIV
6. Experiment aboard shuttle Atlantis will test novel therapy to build bone during space travel
7. High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy
8. EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapy
9. New therapy for childhood neuroblastoma proves feasible and safe
10. Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients
11. Early Talk Therapy May Help Stroke Patients Bounce Back
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology: